Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.
Biomolecules. 2023 Mar 2;13(3):459. doi: 10.3390/biom13030459.
Biomolecules. 2023.
PMID: 36979394
Free PMC article.
Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.
Silva G, Sales-Dias J, Casal D, Alves S, Domenici G, Barreto C, Matos C, Lemos AR, Matias AT, Kucheryava K, Ferreira A, Moita MR, Braga S, Brito C, Cabral MG, Casalou C, Barral DC, Sousa PMF, Videira PA, Bandeiras TM, Barbas A.
Silva G, et al. Among authors: kucheryava k.
Cancers (Basel). 2021 Aug 13;13(16):4074. doi: 10.3390/cancers13164074.
Cancers (Basel). 2021.
PMID: 34439228
Free PMC article.
Item in Clipboard
Development of antibodies against the notch ligand Delta-Like-1 by phage display with activity against breast cancer cells.
Sales-Dias J, Ferreira A, Lamy M, Domenici G, Monteiro SMS, Pires A, Lemos AR, Kucheryava K, Nobre LS, Sousa PMF, Bandeiras TM, Silva G, Barbas A.
Sales-Dias J, et al. Among authors: kucheryava k.
N Biotechnol. 2021 Sep 25;64:17-26. doi: 10.1016/j.nbt.2021.05.003. Epub 2021 May 14.
N Biotechnol. 2021.
PMID: 33992842
Item in Clipboard
Cite
Cite